BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gillis RD, Botteri E, Chang A, Ziegler AI, Chung NC, Pon CK, Shackleford DM, Andreassen BK, Halls ML, Baker JG, Sloan EK. Carvedilol blocks neural regulation of breast cancer progression in vivo and is associated with reduced breast cancer mortality in patients. Eur J Cancer 2021;147:106-16. [PMID: 33639323 DOI: 10.1016/j.ejca.2021.01.029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 De Sanctis R, Viganò A, Torrisi R, Santoro A. Re: Carvedilol blocks neural regulation of breast cancer progression in vivo and is associated with reduced breast cancer mortality in patients: Sympathetic nervous system activity on breast cancer: the story of migraine. Eur J Cancer 2021;152:250-1. [PMID: 34053844 DOI: 10.1016/j.ejca.2021.03.056] [Reference Citation Analysis]
2 Dubowitz J, Hiller J, Riedel B. Anesthetic technique and cancer surgery outcomes. Curr Opin Anaesthesiol 2021;34:317-25. [PMID: 33935180 DOI: 10.1097/ACO.0000000000001002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Archer M, Dogra N, Dovey Z, Ganta T, Jang HS, Khusid JA, Lantz A, Mihalopoulos M, Stockert JA, Zahalka A, Björnebo L, Gaglani S, Noh MR, Kaplan SA, Mehrazin R, Badani KK, Wiklund P, Tsao K, Lundon DJ, Mohamed N, Lucien F, Padanilam B, Gupta M, Tewari AK, Kyprianou N. Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease. Cell Commun Signal 2021;19:78. [PMID: 34284799 DOI: 10.1186/s12964-021-00755-6] [Reference Citation Analysis]
4 Botteri E, Baker JG, Sloan EK. Response to the letter Re: Carvedilol blocks neural regulation of breast cancer progression in vivo and is associated with reduced breast cancer mortality in patients. Eur J Cancer 2021;152:252-4. [PMID: 34099363 DOI: 10.1016/j.ejca.2021.04.022] [Reference Citation Analysis]
5 Abdullah Shamim M, Yeung S, Shahid A, Chen M, Wang J, Desai P, Parsa C, Orlando R, Meyskens FL Jr, Kelly KM, Andresen BT, Huang Y. Topical carvedilol delivery prevents UV-induced skin cancer with negligible systemic absorption. Int J Pharm 2021;:121302. [PMID: 34793935 DOI: 10.1016/j.ijpharm.2021.121302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Løfling LL, Støer NC, Sloan EK, Chang A, Gandini S, Ursin G, Botteri E. β-blockers and breast cancer survival by molecular subtypes: a population-based cohort study and meta-analysis. Br J Cancer 2022. [PMID: 35725814 DOI: 10.1038/s41416-022-01891-7] [Reference Citation Analysis]
7 Hondermarck H, Huang PS, Wagner JA. The nervous system: Orchestra conductor in cancer, regeneration, inflammation and immunity. FASEB Bioadv 2021;3:944-52. [PMID: 34761176 DOI: 10.1096/fba.2021-00080] [Reference Citation Analysis]
8 Lourenço C, Conceição F, Jerónimo C, Lamghari M, Sousa DM. Stress in Metastatic Breast Cancer: To the Bone and Beyond. Cancers 2022;14:1881. [DOI: 10.3390/cancers14081881] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Alhusaini AM, Fadda LM, Alanazi AM, Sarawi WS, Alomar HA, Ali HM, Hasan IH, Ali RA. Nano-Resveratrol: A Promising Candidate for the Treatment of Renal Toxicity Induced by Doxorubicin in Rats Through Modulation of Beclin-1 and mTOR. Front Pharmacol 2022;13:826908. [DOI: 10.3389/fphar.2022.826908] [Reference Citation Analysis]
10 Mravec B. Neurobiology of Cancer: Introduction of New Drugs in the Treatment and Prevention of Cancer. Int J Mol Sci 2021;22:6115. [PMID: 34204103 DOI: 10.3390/ijms22116115] [Reference Citation Analysis]
11 Silva D, Quintas C, Gonçalves J, Fresco P. Contribution of adrenergic mechanisms for the stress-induced breast cancer carcinogenesis. J Cell Physiol 2022. [PMID: 35243626 DOI: 10.1002/jcp.30707] [Reference Citation Analysis]
12 Fu L, Jin W, Zhang J, Zhu L, Lu J, Zhen Y, Zhang L, Ouyang L, Liu B, Yu H. Repurposing non-oncology small-molecule drugs to improve cancer therapy: Current situation and future directions. Acta Pharm Sin B 2022;12:532-57. [PMID: 35256933 DOI: 10.1016/j.apsb.2021.09.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]